Reapra

Investor type

PE / VC

Founded

2015

AUM

-

Location

Singapore

Investment Ticket

$1-5 m

Investment Stage

Series B

Region of investment

Asia
Investor profile last updated: 16 August, 2021

Profile

Our operations and strategies are deeply rooted in well-researched practice, theories and concepts. Through rigourous academic and business research processes, we constantly look towards moving forward with intent and the right knowledge. Armed with our accumulated business insights, we put our theories to the test - via a process of assumption testing, trials, and hands on practices - which Reapra diligently utilizes in refining our business models and strategies.

Industry

Agriculture Education Healthcare Services Real Estate Travel Business Services (B2B) Edtech Medical Devices Pharmaceuticals MedTech Life Sciences Infrastructure HealthTech TravelTech

Contacts

Name
Title
Email
avatar
Shuhei Morofuji CEO & Founder
CEO & Founder
s•••@•••
avatar
Takeo Matsuda Chief Governance Officer
Chief Governance Officer
t•••@•••
Upgrade to see contacts
avatar
V7GRMxXpoKJP3zCL V7GRMxXpoKJP3zCL
V7GRMxXpoKJP3zCL
avatar
V7GRMxXpoKJP3zCL V7GRMxXpoKJP3zCL
V7GRMxXpoKJP3zCL
avatar
V7GRMxXpoKJP3zCL V7GRMxXpoKJP3zCL
V7GRMxXpoKJP3zCL
Investment-team contacts for Reapra — including verified work emails and LinkedIn profiles — are available to Private Equity List subscribers.
Instant access on the web. Plans from $129/month — see pricing.
Contacts sourced from the firm's website and LinkedIn, re-verified on a rolling cycle. Spot a stale contact, or none at all? Report it — we re-run that firm within 48h and get back to you.

FAQs about Reapra

Reapra is a venture capital and private equity firm. It backs companies at Series B, writing tickets of $1-5 m.
Reapra is located in Singapore.
Reapra was founded in 2015.
Reapra invests in companies and startups in Agriculture, Education, Healthcare Services, Real Estate, Travel, Business Services (B2B), Edtech, Medical Devices, Pharmaceuticals, MedTech, Life Sciences, Infrastructure, HealthTech, TravelTech.
Reapra invests in companies and startups in Asia.
Reapra invests in companies and startups at Series B.
Reapra usually invests $1-5 m on average.
Reapra can be reached through its website reapra.com and its LinkedIn page. Its general enquiries address is info@reapra.sg. Cold-mailing a general inbox rarely reaches a partner, so Private Equity List also lists the investment-team contacts for Reapra — names, roles, verified work emails and LinkedIn profiles — available on a Pro plan from $129/month (see pricing). Contacts are sourced from the firm's website and LinkedIn and re-verified on a rolling cycle. Spot a stale contact, or none at all? Report it — we re-run that firm within 48h and get back to you.
Yes. Every field on this page — profile, funds, investment criteria, portfolio and investment-team contacts — is available programmatically through the Private Equity List REST API and MCP server, so AI assistants such as Claude and ChatGPT can query Reapra directly instead of scraping this page. One subscription covers both the web app and machine access — see API & MCP.
Private Equity List re-verifies investor profiles on a rolling cycle, pulling from the firm's own website and LinkedIn rather than a one-off import. This profile was last updated on 16 August, 2021. Something out of date here? Report it — we re-run that firm within 48h and get back to you.